Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Diamidex logo — Make Visible the Invisible Faster to Make your World Safer

Diamidex

Make Visible the Invisible Faster to Make your World Safer

Founded 2014 France France 32 employees Venture round Total: $5.40M Biotechnology, Life Sciences +1

General Information

Company Name Diamidex
Founded Year 2014
Location France France
Employees 32
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Diamidex. To contact Diamidex, visit diamidex.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diamidex compare?

A PDF of Diamidex and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diamidex soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diamidex

Diamidex is a biotechnology startup founded in 2014, with headquarters in France. The company's mission, encapsulated in its slogan "Make Visible the Invisible Faster to Make your World Safer," is to detect and quantify microorganisms of interest rapidly. Diamidex's patented technological approach enables a significant improvement in speed and technicality for microbiological culture, providing turnkey test solutions that deliver results up to 10 times faster than traditional methods.

Recognized by the scientific and industrial communities, Diamidex focuses on various industries, including Biotechnology, Life Sciences, and Medical Devices. The company has attracted a recent €2.50M Venture Round investment on 04 November 2023 from Pure Terra Ventures. Diamidex's comprehensive range of solutions caters to diverse needs across multiple application areas such as Contract Microbiological Laboratories, Bottled Water/Fruit Juices, and Cooling Tower Water, among others.

Business keywords: microbiology, diagnostic technology, quantification technology, bioburden analysis, water quality, turnkey test solutions, bacterial count, industrial microbiology, innovative technology, scientific solutions

Services & Products

Development and implementation of rapid and reliable microbial detection and enumeration solutions for laboratories and industrial facilities

Target Customers

Laboratories industrial facilities and organizations requiring rapid and accurate testing for microbial pathogens in water and related samples

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €2.50M 1
Pure Terra Ventures
Pure Terra Ventures
04 Nov 2023
Debt Financing €900.00K 2
Bpifrance Total Developpement Regional
Bpifrance, Total Developpement Regional
01 Oct 2023
Venture Round €2.00M 2
SATT Sud-Est
SATT Sud-Est, Rugby Angels
01 Oct 2019
Non Equity Assistance Undisclosed 1
Incubateur Impulse
Incubateur Impulse
03 Dec 2013

Diamidex Alternatives & Competitors

View All Alternatives
Diamidex vs
UTI-lizer
UTI-lizer Sweden

Revolutionizes the Urinary Tract Infection diagnostics!

Seed
10 employees
Biotechnology, Medical Devices
Compare Diamidex vs UTI-lizer
Diamidex vs
Novogene Europe
Novogene Europe United Kingdom

Leading Edge Genomic Services & Solutions

Series B
147 employees
Biotechnology, Life Sciences
Compare Diamidex vs Novogene Europe
Diamidex vs
Agilent Technologies
Agilent Technologies United States

Let’s Bring Great Science to Life.

IPO
18344 employees
Biotechnology, Health Care
View all alternatives

FAQ About Diamidex

Make Visible the Invisible Faster to Make your World Safer
Diamidex was founded in 2014.
Diamidex is headquartered in France.
Diamidex operates in Biotechnology, Life Sciences and Medical Devices. Its work centres on microbiology, diagnostic technology, quantification technology and bioburden analysis. Its customers include Laboratories, industrial facilities and and organizations requiring rapid and accurate testing for microbial pathogens in water and related samples.
Diamidex has approximately 32 employees.
Diamidex has completed 4 funding rounds, raising a total of $5.40M. The latest funding stage is Venture round.
Diamidex offers: Development and implementation of rapid and reliable microbial detection and enumeration solutions for laboratories and industrial facilities.
Top alternatives and competitors to Diamidex include UTI-lizer, Novogene Europe, Agilent Technologies, Tiny Bright Things, Applied BioCode, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diamidex and UTI-lizer are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Diamidex, https://bouncewatch.com/company/diamidex, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout